"10.1371_journal.pone.0121662","plos one","2015-03-18T00:00:00Z","Eric J Stavale; Hong Vu; Aruna Sampath; Urban Ramstedt; Kelly L Warfield","Integrated Biotherapeutics, Inc., Gaithersburg, Maryland, United States of America; Unither Virology, LLC, Silver Spring, Maryland, United States of America","Conceived and designed the experiments: EJS HV AS UR KLW. Performed the experiments: EJS HV KLW. Analyzed the data: EJS HV AS UR KLW. Wrote the paper: EJS HV AS UR KLW.","EJS and HV are employees of Integrated Biotherapeutics. Integrated Biotherapeutics received payments to perform studies described in this manuscript through a subcontract under the government contract named in the Financial Disclosure statement, or separately funded by Unither Virology. AS, UR, and KLW are/were employees of Unither Virology. UR and KLW are authors on and have assigned all interests and rights to Unither Virology, certain patents or patent applications relating to material pertinent to this article: \"Methods of treating orthomyxoviral infections\", US application no. 12/873,704; and \"Iminosugars against influenza virus\" and US application no. 62/100,804. Unither Virology is currently developing UV-4B as a therapeutic for treatment of dengue and influenza virus infections. These competing interests do not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2015","03","Eric J Stavale","EJS",5,TRUE,5,3,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
